Actively Recruiting
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-01-07
100
Participants Needed
2
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the proportion of seronegative auto-immune hepatitis and a possible relationship with the severity of the disease. Criteria of severity will be defined by corticodependance, corticoresistance and a severe form of the disease at diagnosis (cirrhosis or fulminant hepatitis). In case of predominant seronegative forms, other auto-antibodies related to this auto-immue hepatitis will be searched.
CONDITIONS
Official Title
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patient followed at Hôpital Saint-Antoine or treated for autoimmune hepatitis (acute or chronic) at CCRD Filfoie in Guadeloupe
- Under immunosuppressive treatment for autoimmune hepatitis
- Affiliated or beneficiary of a social security scheme
- Signed free, informed, and written consent by patient and investigator
You will not qualify if you...
- Under 18 years old
- Unable to give consent
- Viral hepatitis types A to E, Epstein-Barr virus, cytomegalovirus, or herpes simplex virus infection
- Isolated primary biliary cholangitis
- Isolated primary sclerosing cholangitis
- Drug-induced liver injury
- Wilson disease
- Alcoholic hepatitis
- Hemochromatosis
- Sickle cell disease with heart liver involvement
- Non-alcoholic steato-hepatitis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital of Saint-Antoine
Paris, France, France, 75012
Not Yet Recruiting
2
CHU de Pointe-à Pitre
Pointe à Pitre, Guadeloupe, France, 97159
Actively Recruiting
Research Team
V
Valérie SOTER, Promotion Unit manager
CONTACT
E
Eunice NUBRET, Project manager
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here